Of the patients diagnosed with PMS, n = 13 (72%) were treated with DMTs, including interferon beta (n = 5), glatiramer acetate (n = 6), fingolimod (n = 1) and daclizumab (n = 1). Here, IFNB1 is linked to premenstrual tension.